<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CONSOLIDATED BALANCE SHEET AND STATEMENT OF OPERATIONS OF ADVANCED VIRAL RESEARCH CORP FOR THE YEAR ENDED DECEMBER 31, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <PERIOD-TYPE> 12-MOS <FISCAL-YEAR-END> DEC-31-1998 <PERIOD-START> JAN-01-1998 <PERIOD-END> DEC-31-1998 <CASH> 924,420 <SECURITIES> 821,047 <RECEIVABLES> 0 <ALLOWANCES> 0 <INVENTORY> 19,729 <CURRENT-ASSETS> 1,795,014<F1> <PP&E> 1,049,593 <DEPRECIATION> 312,779 <TOTAL-ASSETS> 3,304,953 <CURRENT-LIABILITIES> 317,379 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 2,964 <OTHER-SE> 0 <TOTAL-LIABILITY-AND-EQUITY> 3,304,953 <SALES> 0 <TOTAL-REVENUES> 102,992 <CGS> 0 <TOTAL-COSTS> 0 <OTHER-EXPENSES> 3,190,003 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 1,470,699 <INCOME-PRETAX> (4,557,710) <INCOME-TAX> (4,557,710) <INCOME-CONTINUING> (4,557,710) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (4,557,710) <EPS-BASIC> 0 <EPS-DILUTED> 0 <FN> <F1> PP&E VALUES REPRESENT NET AMOUNTS </FN>